Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06162884 · ClinicalTrials.gov registry record

Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis

A clinical trial of Pulmonary Fibrosis, sponsored by University of California, Los Angeles.

Recruiting
Registry status
200
Enrollment target
1
Study location

NCT06162884: Recruiting study of Pulmonary Fibrosis, sponsored by University of California, Los Angeles.

NCT06162884 is a study of Pulmonary Fibrosis that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 200 participants, below the 880-participant average among 22 other Pulmonary Fibrosis trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06162884, a study of Pulmonary Fibrosis, is actively recruiting participants, sponsored by University of California, Los Angeles.

RECRUITING
Registry status
200 participants
Enrollment target
1
Study location

Study Summary

This study is a prospective observational study for subjects with idiopathic pulmonary fibrosis (IPF) or non-IPF interstitial lung diseases (ILD). The purpose of this study is to compare whether imaging patterns from high-resolution computed tomography (HRCT) at baseline can predict worsening. Single Time point Prediction (STP) is a score derived from an artificial intelligenc/ machine learning (AI/ML) using the radiomic features from a HRCT scan that quantifies the imaging patterns of short-term predictive worsening.

Primary Outcome

PFS of IPF and non-IPF ILD will be compared in patients with STP \>=30% or \<30%. A higher STP score, ranging from 0% to 100%, indicates a worse outcome. Progression is uniformly defined in both IPF and non-IPF ILD population as the reduction of FVC \>=10% or the reduction of DLCO \>=15% or death due to the disease.

Conditions Studied

Pulmonary Fibrosis

Study Locations (1)

California

  • UCLA - Los Angeles

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2024-11-06
Est. Completion 2028-08-19
University of California, Los Angeles

897 total trials

What NCT06162884 shows while recruiting

NCT06162884 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 880-participant average among 22 other Pulmonary Fibrosis trials with a reported enrollment target (77% lower).

The record links to 1 condition, with Pulmonary Fibrosis appearing as the primary indexed condition, and to 0 interventions.

NCT06162884 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06162884 about?

NCT06162884 is a clinical study titled "Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis". This study is a prospective observational study for subjects with idiopathic pulmonary fibrosis (IPF) or non-IPF interstitial lung diseases (ILD). The purpose of this study is to compare whether imaging patterns from high-resolution computed tomography (HRCT) at baseline can predict worsening. Sing...

What is the current status of trial NCT06162884?

This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2024-11-06. Estimated completion is 2028-08-19.

What conditions does trial NCT06162884 study?

This clinical trial studies the following conditions: Pulmonary Fibrosis.

Who is sponsoring clinical trial NCT06162884?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06162884 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pulmonary Fibrosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06162884's enrollment target sits among peer trials

200 9th of 22 higher than 14 of 22 other Pulmonary Fibrosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pulmonary Fibrosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06162884

Source: ClinicalTrials.gov NCT06162884, the US trial registry maintained by the National Library of Medicine. NCT06162884 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.